MY144229A - Pyridazine derivatives and their use as therapeutic agents - Google Patents

Pyridazine derivatives and their use as therapeutic agents

Info

Publication number
MY144229A
MY144229A MYPI20060384A MY144229A MY 144229 A MY144229 A MY 144229A MY PI20060384 A MYPI20060384 A MY PI20060384A MY 144229 A MY144229 A MY 144229A
Authority
MY
Malaysia
Prior art keywords
therapeutic agents
pyridazine derivatives
mammal
formula
disclosed
Prior art date
Application number
Inventor
Melwyn Abreo
Vishnumurthy Kodumuru
Wenbao Li
Shifeng Liu
Vandna Raina
Sengen Sun
Shaoyi Sun
Serguei Sviridov
Shi Tu
Michael D Winther
Zaihui Zhang
Mikhail Chafeev
Nagasree Chakka
Sultan Chowdhury
Jian-Min Fu
Heinz W Gschwend
Mark W Holladay
Duanjie Hou
Rajender Kamboj
Original Assignee
Xenon Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xenon Pharmaceuticals Inc filed Critical Xenon Pharmaceuticals Inc
Priority to MYPI20060384 priority Critical patent/MY144229A/en
Publication of MY144229A publication Critical patent/MY144229A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

METHODS OF TREATING AN SCD-MEDIATED DISEASE OR CONDITION IN A MAMMAL, PREFERABLY A HUMAN, ARE DISCLOSED, WHEREIN THE METHODS COMPRISE ADMINISTERING TO A MAMMAL IN NEED THEREOF A COMPOUND OF FORMULA (1): WHERE X, Y, W. V, R 2,R3 R 4 R 5, R6, R6A R7, R7A, R8, R8A , R9 AND R9A ARE DEFINED HEREIN. PHARMACEUTICAL COMPOSITIONS COMPRISING THE COMPOUNDS OF FORMULA (1) ARE ALSO DISCLOSED.
MYPI20060384 2006-01-26 2006-01-26 Pyridazine derivatives and their use as therapeutic agents MY144229A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MYPI20060384 MY144229A (en) 2006-01-26 2006-01-26 Pyridazine derivatives and their use as therapeutic agents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MYPI20060384 MY144229A (en) 2006-01-26 2006-01-26 Pyridazine derivatives and their use as therapeutic agents

Publications (1)

Publication Number Publication Date
MY144229A true MY144229A (en) 2011-08-15

Family

ID=45024033

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20060384 MY144229A (en) 2006-01-26 2006-01-26 Pyridazine derivatives and their use as therapeutic agents

Country Status (1)

Country Link
MY (1) MY144229A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10703712B2 (en) 2015-09-16 2020-07-07 Metacrine, Inc. Farnesoid X receptor agonists and uses thereof
US10927082B2 (en) 2017-03-15 2021-02-23 Metacrine, Inc. Farnesoid X receptor agonists and uses thereof
US11084817B2 (en) 2018-09-18 2021-08-10 Metacrine, Inc. Farnesoid X receptor agonists and uses thereof
US11236071B1 (en) 2017-03-15 2022-02-01 Metacrine, Inc. Farnesoid X receptor agonists and uses thereof
US12491160B2 (en) 2020-03-18 2025-12-09 Eli Lilly And Company Formulations of a farnesoid X receptor agonist
US12545660B2 (en) 2020-03-18 2026-02-10 Eli Lilly And Company Crystalline forms of a farnesoid X receptor agonist

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10703712B2 (en) 2015-09-16 2020-07-07 Metacrine, Inc. Farnesoid X receptor agonists and uses thereof
US11214538B2 (en) 2015-09-16 2022-01-04 Metacrine, Inc. Farnesoid X receptor agonists and uses thereof
US10927082B2 (en) 2017-03-15 2021-02-23 Metacrine, Inc. Farnesoid X receptor agonists and uses thereof
US10961198B2 (en) 2017-03-15 2021-03-30 Metacrine, Inc. Farnesoid X receptor agonists and uses thereof
US11236071B1 (en) 2017-03-15 2022-02-01 Metacrine, Inc. Farnesoid X receptor agonists and uses thereof
US11084817B2 (en) 2018-09-18 2021-08-10 Metacrine, Inc. Farnesoid X receptor agonists and uses thereof
US11773094B2 (en) 2018-09-18 2023-10-03 Organovo, Inc. Farnesoid X receptor agonists and uses thereof
US12491160B2 (en) 2020-03-18 2025-12-09 Eli Lilly And Company Formulations of a farnesoid X receptor agonist
US12545660B2 (en) 2020-03-18 2026-02-10 Eli Lilly And Company Crystalline forms of a farnesoid X receptor agonist

Similar Documents

Publication Publication Date Title
MY141939A (en) Pyridazine derivatives and their use as therapeutic agents
TNSN06032A1 (en) Pyridazine derivatives and their use as therapeutic agents
TNSN06034A1 (en) Pyridazine derivatives and their use as therapeutic agents
TW200626138A (en) Heterocyclic derivatives and their use as therapeutic agents
IL173397A0 (en) Pyridyl derivatives and their use as therapeutic agents
TW200624427A (en) Heterocyclic derivatives and their use as therapeutic agents
TW200626592A (en) Heterocyclic derivatives and their use as therapeutic agents
TW200626139A (en) Heterocyclic derivatives and their use as therapeutic agents
TW200626154A (en) Heterocyclic derivatives and their use as therapeutic agents
TW200626153A (en) Heterocyclic derivatives and their use as therapeutic agents
TW200626572A (en) Heterocyclic derivatives and their use as therapeutic agents
TW200626148A (en) Heterocyclic derivatives and their use as therapeutic agents
TW200626155A (en) Heterocyclic derivatives and their use as therapeutic agents
TNSN06033A1 (en) Piperazine derivatives and their use as therapeutic agents
TNSN06036A1 (en) Pyridyl derivatives and their use as therapeutic agents
MX2007000028A (en) Nicotinamide derivatives and their use as therapeutic agents.
WO2007044085A3 (en) Heteroaryl compounds and their uses as therapeutic agents
WO2007046868A3 (en) Thiazolidine derivatives and their uses as therapeutic agents
WO2007046867A3 (en) Piperidine derivatives and their uses as therapeutic agents
WO2006125194A3 (en) Piperazine derivatives and their uses as therapeutic agents
MY144229A (en) Pyridazine derivatives and their use as therapeutic agents
JO2829B1 (en) Pyridazine Derivatives and their use as Therapeutic agents